IDiyas

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10351830 B1

PDFFull Text
Date of Patent:
Jul. 16, 2019

Filed:

Dec. 11, 2015

Conjugates for assays for oxycodone and oxymorphone

Applicant:

Siemens Healthcare Diagnostics Inc., Tarrytown, NY (US);

Inventors:

Yi Feng Zheng, Wilmington, DE (US);

Yali Yang, Bear, DE (US);

Guoping Wang, Newark, DE (US);

Assignee:

Siemens Healthcare Diagnostics Inc., Tarrytown, NY (US);

Attorney:

Cynthia G. Tymeson

Primary Examiner:

Shafiqul Haq

Int. Cl.
CPC ...
G01N 33/58 (2006.01); G01N 33/94 (2006.01); G01N 33/535 (2006.01); C07K 16/44 (2006.01); C07D 317/58 (2006.01); C12N 9/04 (2006.01); C07D 489/02 (2006.01); C07D 489/08 (2006.01); C07D 405/12 (2006.01); C12Q 1/28 (2006.01); G01N 33/569 (2006.01);
U.S. Cl.
CPC ...
C12N 9/0006 (2013.01); C07D 317/58 (2013.01); C07D 405/12 (2013.01); C07D 489/02 (2013.01); C07D 489/08 (2013.01); C07K 16/44 (2013.01); C12Q 1/28 (2013.01); G01N 33/535 (2013.01); G01N 33/56911 (2013.01); G01N 33/581 (2013.01); G01N 33/94 (2013.01); G01N 33/9486 (2013.01);
Abstract

Compositions, methods, and kits are disclosed directed at haptens, immunogens and immunoassays for oxycodone and metabolites thereof. The compounds are exemplified by compounds of the Formula I. The method comprises providing in combination in a medium (i) a sample suspected of containing oxycodone and/or oxycodone metabolites, a compound of the Formula I wherein Ror Ris a label, and an antibody for oxycodone or a metabolite thereof. The medium is examined for the presence of a complex comprising the labeled compound of Formula I where the presence of such as complex indicates the presence of oxycodone or oxycodone metabolite in the sample.

Find Patent Forward Citations

Loading…